Pharmgate to Showcase Swine Vaccine Innovations at VIV Asia 2025

Wilmington, February 27, 2025 – Pharmgate is pleased to announce our participation in VIV Asia 2025, one of the premier global events for animal health and agribusiness. Taking place from March 12-14 in Bangkok, Thailand, VIV Asia brings together industry leaders, experts, and producers from across the region.

At Booth 3-4620, we will highlight our comprehensive swine vaccine portfolio designed to support producers in enhancing herd health and productivity. Our solutions are backed by scientific research and industry expertise, ensuring reliable disease prevention strategies for modern swine operations.

One of the key highlights at VIV Asia will be the introduction of PRRSGard, our latest innovation in PRRS vaccine technology. Set to launch later in 2025, PRRSGard is designed to address the ongoing challenges of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), providing producers with an advanced tool for disease management.

Meet Our Leadership Team at VIV Asia

Our global team will be available throughout the event to engage in meaningful discussions and explore potential partnerships. We invite you to visit Booth 3-4620 and connect with us to discuss how Pharmgate’s vaccine solutions can contribute to the long-term success of your business.

 

About Pharmgate
Pharmgate Animal Health provides the livestock and poultry industry with a proven portfolio of technically supported, high-quality products that are the foundation of the custom herd health protocols. Founded in 2008, the company is headquartered in Wilmington, North Carolina, with FDA-approved pharmaceutical production facilities in Omaha, Nebraska, and CVM vaccine research and manufacturing operations in St. Paul, Minnesota. To learn more about Pharmgate Animal Health, or to find a local representative, visit pharmgate.com/global/

For more information please contact:

Pharmgate Animal Health
Leslie Gray
Global Distribution Manager
Phone +35 38 7351 2708
Leslie.Gray@Pharmgate.com

Leave a Reply

Your email address will not be published. Required fields are marked *